GlassScriptPhysician profile
Prashanth C Chandra Sekhar
NPI 1861612103
$9,317.82
in general payments reported to CMS, 2019-2025
47 companies · $1,437 in 2025
The $1,437 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $1,015 · 2021: $1,743 · 2022: $871 · 2023: $1,801 · 2024: $1,150 · 2025: $1,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,317 · Entertainment: $70.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,317.46 |
| Entertainment | $70.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $892.62 | 2019-2025 | Taltz, Mounjaro, Jardiance |
| Dexcom, INC. | $637.86 | 2019-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $574.37 | 2019-2025 | Freestyle Libre 3, Bigfoot Unity Diabetes Management System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $551.11 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $518.51 | 2019-2024 | |
| Novo Nordisk INC | $483.94 | 2019-2025 | Ozempic, Rybelsus |
| Insulet Corporation | $472.28 | 2019-2025 | Omnipod |
| Amgen INC. | $459.20 | 2019-2025 | Evenity, Tepezza, Prolia |
| Xeris Pharmaceuticals, INC. | $419.98 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $411.71 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $368.32 | 2019-2025 | Saphnelo |
| Corcept Therapeutics | $308.61 | 2019-2025 | Korlym |
| Janssen Biotech, INC. | $273.07 | 2023-2025 | Tremfya |
| Esperion Therapeutics, INC. | $266.17 | 2020-2021 | |
| Cequr Corporation | $248.33 | 2023-2025 | Cequr Simplicity |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $243.64 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ibsa Pharma INC. | $227.54 | 2021-2025 | Tirosint, Tirosint, Licart |
| Abbvie INC. | $196.67 | 2019-2021 | |
| Radius Health, INC. | $174.72 | 2020-2025 | Tymlos |
| Pfizer INC. | $164.14 | 2019-2024 | |
| Amarin Pharma, INC. | $122.31 | 2020-2021 | |
| Ucb, INC. | $113.15 | 2023-2025 | Cimzia, Bimzelx |
| Bayer Healthcare Pharmaceuticals INC. | $93.34 | 2021-2024 | |
| Antares Pharma, INC. | $92.23 | 2019-2025 | Xyosted |
| Sequel Med Tech, LLC | $87.86 | 2025 | Twiist |
| Merck Sharp & Dohme LLC | $83.22 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $80.02 | 2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $75.06 | 2022-2025 | Strensiq |
| Optos, INC. | $70.31 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Averitas Pharma INC. | $64.40 | 2023-2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $59.97 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $56.48 | 2019 | |
| Nevro Corp. | $52.04 | 2023-2024 | Senza |
| Fresenius Kabi USA, LLC | $49.42 | 2024 | Idacio |
| Lifescan, INC. | $43.30 | 2019-2020 | |
| Kyowa Kirin, INC. | $37.83 | 2023 | Crysvita |
| Shire North American Group INC | $36.28 | 2019 | |
| Horizon Therapeutics Plc | $29.00 | 2022 | |
| Sandoz INC. | $26.35 | 2023 | Hyrimoz |
| Amneal Pharmaceuticals LLC | $22.43 | 2025 | Unithroid |
| Ultragenyx Pharmaceutical INC. | $21.77 | 2021 | |
| Clarus Therapeutics INC. | $19.42 | 2021 | |
| Recordati_rare_diseases_inc. | $18.81 | 2023 | Isturisa, Signifor Lar |
| Sobi, INC | $18.59 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.13 | 2022 | |
| Mannkind Corporation | $16.87 | 2025 | |
| Genentech USA, INC. | $16.44 | 2025 | Actemra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashanth Chandra Sekhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.